Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin/clavulanic acid for GAS-colonized children with chronic tic disorder
NL-OMON53389Phase 4Active, not recruiting
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in tic disorder and Tourette syndrome (TS) comparing Amoxicillin/clavulanic acid with Placebo (2 arms). Primary endpoint: Yale Global Tic Severity Scale. Started Aug 2013; status: active, not recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
tic disorderTourette syndrome (TS)
Beyond the preview
Go deeper on NL-OMON53389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53389.